Maxicuma®

Videos

Information

Maxicuma® is a clinically studied, clean label ingredient from turmeric, standardised to 40% curcuminoids that helps improve joint pain, stiffness, mobility and physical performance at an ultra-low dose of 100-250mg/day. Formulated with proprietary technology platform, LIMAN™ (Lecithin based Liposomal Microencapsulation), Maxicuma® exhibits enhanced solubility delivering 172 folds higher levels of free curcumin in the human blood plasma than conventional curcumin extract, facilitating better absorption and the bio efficacy thereof.

India Glycols Ltd.5280Grounded in the principles of Nature, Technology, and Innovation, Ennature Biopharma specializes in the development and production of complex phytopharmaceutical and nutraceutical actives. Our proprietary technology platforms, LIMAN™ and SCEMOD™, enable the creation of high-efficacious plant-based ingredients. Our team of over 30 in-house scientists works on different research platforms like phytochemistry, analytical research and development, pharmacology, toxicology, biotechnology, formulation development, etc., to curate effective, natural health solutions that meet global standards. We maintain a fully traceable, backward-integrated supply chain for biomass sourcing. Our commitment to quality is demonstrated through global accreditations, including U.S. FDA, WHO-GMP, ISO 9001, ISO 22000, HACCP, Halal, and Kosher certifications.